Seikagaku Corp (4548)

Tokyo
Currency in JPY
790.0
-3.0(-0.38%)
Closed
4548 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
787.0797.0
52 wk Range
730.0914.0
Key Statistics
Edit
Bid/Ask
790.00 / 796.00
Prev. Close
793
Open
794
Day's Range
787-797
52 wk Range
730-914
Volume
71.8K
Average Vol. (3m)
69.51K
1-Year Change
2.73%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4548 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth
Show more

Seikagaku Corp Company Profile

Seikagaku Corporation manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan and internationally.The company operates in two segments, Pharmaceuticals and LAL Business. It offers pharmaceuticals and medical devices, including intra-articular injections for improving joint functions under the brands of ARTZ, ARTZ Dispo, VISCO-3, JOYCLU Gel-One, Hylink, and SUPARTZ FX; ophthalmic surgical aids under the OPEGAN and SHELLGAN brands; surgical aids for endoscopic mucosal resection under the brand name of MucoUp; and HERNICORE for the treatment of lumbar disc herniation. The company also offers bulk products comprising sodium hyaluronate and sodium chondroitin sulfate for use in pharmaceuticals and cosmetics. In addition, it develops endotoxin-detecting reagents for use in quality control of injectable pharmaceuticals and medical devices manufacturing processes and water quality control of dialysate under the brands, such as Pyrochrome, ENDOSPECY, TOXICOLOR, etc. Additionally, its products under development include SI-6603 for lumbar disc herniation; SI-614, a modified hyaluronate for dry eyes; SI-613 for knee osteoarthritis; SI-722 to treat interstitial cystitis and bladder pain syndrome; SI-613-ETP to treat enthesopathy; and SI-449, a cross-linked chondroitin sulfate adhesion barrier. The company was formerly known as K.K. Seikagaku Kenkyusho and changed its name to Seikagaku Corporation in 1962. Seikagaku Corporation was founded in 1947 and is headquartered in Tokyo, Japan.

Employees
988
Market
Japan

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 47.15%
Dividend Yield
3.78%
Industry Median 2.29%
Annualized Payout
30.00
Paid unevenly
5-Years Growth
+1.49%
Growth Streak

Earnings

Latest Release
Feb 07, 2025
EPS / Forecast
21.21 / --
Revenue / Forecast
10.24B / 9.589B
EPS Revisions
Last 90 days

FAQ

What Is the Seikagaku Corp (4548) Stock Price Today?

The Seikagaku Corp stock price today is 790.00

What Stock Exchange Does Seikagaku Corp Trade On?

Seikagaku Corp is listed and trades on the Tokyo stock exchange.

What Is the Stock Symbol for Seikagaku Corp?

The stock symbol for Seikagaku Corp is "4548."

Does Seikagaku Corp Pay Dividends? What’s The Current Dividend Yield?

The Seikagaku Corp dividend yield is 3.80%.

What Is the Seikagaku Corp Market Cap?

As of today, Seikagaku Corp market cap is 43.12B.

What is Seikagaku Corp Earnings Per Share?

The Seikagaku Corp EPS is 47.15.

What Is the Next Seikagaku Corp Earnings Date?

Seikagaku Corp will release its next earnings report on May 09, 2025.

From a Technical Analysis Perspective, Is 4548 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.